Eton Pharmaceuticals Inc. (NASDAQ: ETON)
$12.6800
+0.0200 ( +1.52% ) 34.6K
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
Market Data
Open
$12.6800
Previous close
$12.6600
Volume
34.6K
Market cap
$329.81M
Day range
$11.3850 - $12.7310
52 week range
$3.0300 - $13.9800
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 14 | Jun 11, 2024 |
10-q | Quarterly Reports | 60 | May 09, 2024 |
8-k | 8K-related | 15 | May 09, 2024 |
8-k | 8K-related | 15 | Apr 30, 2024 |
def | Proxies and info statements | 21 | Apr 26, 2024 |
8-k | 8K-related | 14 | Apr 18, 2024 |
8-k | 8K-related | 15 | Mar 22, 2024 |
10-k/a | Quarterly Reports | 18 | Mar 22, 2024 |
10-k | Annual reports | 78 | Mar 14, 2024 |
8-k | 8K-related | 16 | Mar 14, 2024 |